Literature DB >> 19854517

Early regulators in abortion and implications for a preeclampsia model.

Gérard Chaouat1, Marie Petitbarat, Roberta Bulla, Sylvie Dubanchet, Karina Valdivia, Nathalie Ledée, Thiel Steffen, Jens Christian Jensenius, Francesco Tedesco.   

Abstract

This paper reports a summary of our comparative analysis of the uterine expression of interleukin-23 (IL-23), IL-27 and TWEAK in the CBA/J femalexDBA/2 male mouse mating combination, a model of immune-mediated early pregnancy loss. Compared with the MHC-identical CBA/JxBALB/c mating combination, which yields successful pregnancies, immunohistochemistry and qPCR in uterine tissue showed an immediate post-mating IL-27 hyper-expression after mating with DBA/2 males. Intra-uterine TWEAK expression was present in females mated with DBA/2 or Balb/c males from days 0.5 to 4.5 post-coitum (pc), peaking on day 0.5 pc together with uterine TNFalpha. In uteri of DBA/2 mated mice, TWEAK declined to almost undetectable levels on days 6.5-9.5 pc, a steeper drop than in BALB/c mated mice where TWEAK remained detectable. In both mating combinations, neutralisation of TWEAK by antibodies increased resorption rates, but surprisingly, so did IL-27 neutralisation. The complement regulator mannan binding lectin-A (MBL-A), but not MBL-C, was present on day 4.5 pc especially after mating with DBA/2 males. High levels of MBL are present in the uterine luminal fluid of sterile women, and possible functions for TWEAK and MBL in human implantation are indicated by their protein and mRNA expression in uterine biopsies from infertile and fertile individuals. Consistent with the results in mice, increased MBL expression is linked with pregnancy failure. Serum and uterine VEGF and VEGF receptor levels are also different between fertile and sterile patients. The implications of these findings for utilising the CBA/JxDBA/2 mating combination as an early onset model of preeclampsia are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854517     DOI: 10.1016/j.jri.2009.08.004

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  6 in total

Review 1.  Mouse is the new woman? Translational research in reproductive immunology.

Authors:  David A Clark
Journal:  Semin Immunopathol       Date:  2016-01-18       Impact factor: 9.623

Review 2.  The complement system and adverse pregnancy outcomes.

Authors:  Jean F Regal; Jeffrey S Gilbert; Richard M Burwick
Journal:  Mol Immunol       Date:  2015-03-21       Impact factor: 4.407

3.  Complement factor B activation in patients with preeclampsia.

Authors:  Ivan Velickovic; Mudar Dalloul; Karen A Wong; Olufunke Bakare; Franz Schweis; Maya Garala; Amit Alam; Giorgio Medranda; Jovana Lekovic; Waqas Shuaib; Andreas Tedjasukmana; Perry Little; Daniel Hanono; Ruvini Wijetilaka; Jeremy Weedon; Jun Lin; Roulhac d'Arby Toledano; Ming Zhang
Journal:  J Reprod Immunol       Date:  2015-01-03       Impact factor: 4.054

4.  Neonatal macrophages express elevated levels of interleukin-27 that oppose immune responses.

Authors:  Jennifer D Kraft; Joseph Horzempa; Celestia Davis; Joo-Yong Jung; Maria Marjorette O Peña; Cory M Robinson
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

5.  Endogenous TWEAK is critical for regulating the function of mouse uterine natural killer cells in an immunological model of pregnancy loss.

Authors:  Xuefeng Qi; Mingzhu Lei; Lijuan Qin; Mengjie Xie; Dandan Zhao; Jingyu Wang
Journal:  Immunology       Date:  2016-03-02       Impact factor: 7.397

Review 6.  COVID-19, Pre-Eclampsia, and Complement System.

Authors:  Chiara Agostinis; Alessandro Mangogna; Andrea Balduit; Azin Aghamajidi; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.